EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs

Hong Huo, Jinming Wang, Chan Li, Shuang Xiao, Han Wang, Jinying Ge, Gongxun Zhong, Zhiyuan Wen, Chong Wang, Qiaoling Lang, Lili Chen, Zilong Wang und 6 weitere

Frontiers in Cellular and Infection Microbiology · 2024

DOI: 10.3389/fcimb.2024.1468775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2024. Verfasst von Hong Huo und 17 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbi…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, Antibodies, Viral, SARS-CoV-2, Antibodies, Neutralizing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Minks, cats, and some other species of carnivores are susceptible of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and have a high risk of transmitting SARS-CoV-2 to humans. The development of animal vaccines can be an effective measure to protect animals against SARS-CoV-2 and reduce the potential risk of human infection. We previously developed a messenger ribonucleic acid (mRNA) vaccine SYS6006 that has been proven to be an efficient coronavirus disease 2019 (COVID-19) vaccine widely used in humans. Here, we further evaluated the safety and immunogenicity of SYS6006 as an animal COVID-19 vaccine candidate for SARS-CoV-2 susceptible animals or wild animals. SYS6006 was safe and immunogenic in mice and completely protected mice against mouse-adapted SARS-CoV-2 infection in the upper and lower respiratory tracts. SYS6006 was able to induce neutralizing antibodies against the SARS-CoV-2 wild-type, Delta, and Omicron BA.2 strain on day 7 after prime immunization, and two doses of immunization could enhance the neutralizing antibody responses and produce long-lasting potent antibodies for more than 8 months in minks and cats, blue foxes, and raccoon dogs, while all immunized animals had no abnormal clinical signs during immunization. These results provided here warrant further development of this safe and efficacious mRNA vaccine platform against animal COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesAntibodies, ViralSARS-CoV-2Antibodies, NeutralizingRaccoon DogsCOVID-19FoxesmRNA VaccinesAnimalsCatsMiceFemaleMice, Inbred BALB CImmunogenicity, Vaccine

Stichwörter der Autor:innen

SARS-CoV-2mRNA vaccineneutralizing antibodysafetysusceptible animals

Substanzen

COVID-19 VaccinesAntibodies, ViralAntibodies, NeutralizingmRNA VaccinesSYS6006 COVID-19 vaccine

Autor:innen und Institutionen

  • State Key Laboratory for Animal Disease Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
  • National High Containment Laboratory for Animal Diseases Control and Prevention, Harbin Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Harbin, China.
  • CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd., CSPC Pharmaceutical Group Co., Ltd., Shijiazhuang, Hebei, China.
  • Jiangsu Co-innovation Center for Prevention and Control of Important Animal Infectious Diseases and Zoonoses, Yangzhou University, Yangzhou, China.

Zitieren

APA

Huo, H., Wang, J., Li, C., Xiao, S., Wang, H., Ge, J., Zhong, G., Wen, Z., Wang, C., Lang, Q., Chen, L., Wang, Z., Wang, J., Wang, X., He, X., Guan, Y., Shuai, L., & Bu, Z. (2024). Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1468775

Vancouver

Huo H, Wang J, Li C, Xiao S, Wang H, Ge J, et al. Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs. Frontiers in Cellular and Infection Microbiology. 2024. doi:10.3389/fcimb.2024.1468775

BibTeX
@article{Huo2024,
  author = {Huo, Hong and Wang, Jinming and Li, Chan and Xiao, Shuang and Wang, Han and Ge, Jinying and Zhong, Gongxun and Wen, Zhiyuan and Wang, Chong and Lang, Qiaoling and Chen, Lili and Wang, Zilong and Wang, Jinliang and Wang, Xijun and He, Xijun and Guan, Yuntao and Shuai, Lei and Bu, Zhigao},
  title = {Safety and immunogenicity of a SARS-CoV-2 mRNA vaccine (SYS6006) in minks, cats, blue foxes, and raccoon dogs},
  journal = {Frontiers in Cellular and Infection Microbiology},
  year = {2024},
  doi = {10.3389/fcimb.2024.1468775}
}
Kostenlos starten →